Cipla Therapeutics partners with SIGA Technologies for antibacterial drugs
Cipla Therapeutics, an Indian pharma company, and SIGA Technologies have entered into a partnership to provide sustained innovation and access to novel antibacterial drugs, especially against biothreats. SIGA Technologies is a US-based commercial-stage pharmaceutical company, whose lead product is TPOXX. Also called tecovirimat and ST-246, TPOXX is an orally administered and intravenous (IV) formulation antiviral […]